Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 4771 AL 4785

Esculetin: A review of its pharmacology and pharmacokinetics

Zhang L, Xie Q, Li X.

Phytother Res. 2022 Jan;36(1):279-298. doi: 10.1002/ptr.7311. Epub 2021 Nov 22.

A systematic review of the prognostic value of motor abnormalities on clinical outcome in psychosis

Pieters LE, Nadesalingam N, Walther S, van Harten PN.

Neurosci Biobehav Rev. 2022 Jan;132:691-705. doi: 10.1016/j.neubiorev.2021.11.027. Epub 2021 Nov 20.

Gastrointestinal mucosal biopsies in Parkinson's disease: beyond alpha-synuclein detection

Derkinderen P, Cossais F, de Guilhem de Lataillade A, Leclair-Visonneau L, Neunlist M, Paillusson S, De Giorgio R.

J Neural Transm (Vienna). 2022 Sep;129(9):1095-1103. doi: 10.1007/s00702-021-02445-6. Epub 2021 Nov 24.

Parkinson's Disease Modification Through Abl Kinase Inhibition: An Opportunity

Werner MH, Olanow CW.

Mov Disord. 2022 Jan;37(1):6-15. doi: 10.1002/mds.28858. Epub 2021 Nov 23.

Respiratory disorders of Parkinson's disease

Aquino YC, Cabral LM, Miranda NC, Naccarato MC, Falquetto B, Moreira TS, Takakura AC.

J Neurophysiol. 2022 Jan 1;127(1):1-15. doi: 10.1152/jn.00363.2021. Epub 2021 Nov 24.

Non-coding regulatory elements: Potential roles in disease and the case of epilepsy

Pagni S, Mills JD, Frankish A, Mudge JM, Sisodiya SM.

Neuropathol Appl Neurobiol. 2022 Apr;48(3):e12775. doi: 10.1111/nan.12775. Epub 2021 Dec 16.

Advancements and future directions in research of the roles of insulin in amyloid diseases

Miller Y.

Biophys Chem. 2022 Feb;281:106720. doi: 10.1016/j.bpc.2021.106720. Epub 2021 Nov 17.

Multicenter Validation of Individual Preoperative Motor Outcome Prediction for Deep Brain Stimulation in Parkinson's Disease

Habets JGV, Herff C, Fasano AA, Beudel M, Kocabicak E, Schnitzler A, Snineh MA, Kalia SK, Ramirez-Gómez C, Hodaie M, Munhoz RP, Rouleau E, Yildiz O, Linetsky E, Schuurman R, Hartmann CJ, Lozano AM, De Bie RMA, Temel Y, Janssen MLF.

Stereotact Funct Neurosurg. 2022;100(2):121-129. doi: 10.1159/000519960. Epub 2021 Nov 25.

Designing nanoformulation for the nose-to-brain delivery in Parkinson's disease: Advancements and barrier

Kiran P, Debnath SK, Neekhra S, Pawar V, Khan A, Dias F, Pallod S, Srivastava R.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022 Jan;14(1):e1768. doi: 10.1002/wnan.1768. Epub 2021 Nov 25.

Review of Metabolomics-Based Biomarker Research for Parkinson's Disease

Li X, Fan X, Yang H, Liu Y.

Mol Neurobiol. 2022 Feb;59(2):1041-1057. doi: 10.1007/s12035-021-02657-7. Epub 2021 Nov 26.

Cannabis: Chemistry, extraction and therapeutic applications

Pattnaik F, Nanda S, Mohanty S, Dalai AK, Kumar V, Ponnusamy SK, Naik S.

Chemosphere. 2022 Feb;289:133012. doi: 10.1016/j.chemosphere.2021.133012. Epub 2021 Nov 25.

Antioxidative role of Traditional Chinese Medicine in Parkinson's disease

Muhammad F, Liu Y, Zhou Y, Yang H, Li H.

J Ethnopharmacol. 2022 Mar 1;285:114821. doi: 10.1016/j.jep.2021.114821. Epub 2021 Nov 25.

Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson's Disease - The RESISTA-PD Trial

Becker A, Schmartz GP, Gröger L, Grammes N, Galata V, Philippeit H, Weiland J, Ludwig N, Meese E, Tierling S, Walter J, Schwiertz A, Spiegel J, Wagenpfeil G, Faßbender K, Keller A, Unger MM.

Genomics Proteomics Bioinformatics. 2022 Apr;20(2):274-287. doi: 10.1016/j.gpb.2021.08.009. Epub 2021 Nov 25.

A heterozygous de novo PSEN1 mutation in a patient with early-onset parkinsonism

Chen Y, Liu P, Xie F, Wang B, Lin Z, Luo W.

Neurol Sci. 2022 Feb;43(2):1405-1409. doi: 10.1007/s10072-021-05726-w. Epub 2021 Nov 29.

The Impact of Alcohol-Induced Dysbiosis on Diseases and Disorders of the Central Nervous System

Liu X, Vigorito M, Huang W, Khan MAS, Chang SL.

J Neuroimmune Pharmacol. 2022 Jun;17(1-2):131-151. doi: 10.1007/s11481-021-10033-4. Epub 2021 Nov 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias